SMMT — Summit Therapeutics Share News
0.000.00%
Last trade - 00:00- $10.87bn
- $10.28bn
Brief: Summit Therapeutics Raises $500 Million in Private Placement
U.S. STOCKS ON THE MOVE-Arm Holdings, silver miners, Zions Bancorp
U.S. STOCKS ON THE MOVE-Apple, Zoom, Arm Holdings
Summit slides after not disclosing overall survival benefit in lung cancer trial
U.S. STOCKS ON THE MOVE-Glaukos, Reddit, Micron
Summit falls after not disclosing overall survival benefit in lung cancer trial
Brief: Summit Therapeutics To Host Esmo Data Update & Third Quarter Earnings Call On October 20, 2025
Brief: Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Summit shares tumble on mixed data for lung cancer drug (updated)
Summit shares tumble on mixed data for lung cancer drug
Summit Therapeutics slides after mixed data for lung cancer drug
AstraZeneca beats second-quarter profit expectations, maintains outlook (updated)
AstraZeneca beats second-quarter profit expectations
UK Stocks-Factors to watch on July 4 (updated)
UK Stocks-Factors to watch on July 4
U.S. STOCKS ON THE MOVE-Lucid, Nvidia, CrowdStrike
Summit Therapeutics up on report of talks for licensing deal with AstraZeneca
Summit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reports (updated)
Summit considers up to $15 billion partnership with AstraZeneca, Bloomberg News reports